2010Unpublished venueRequires access

Donepezil, Rivastigmine and Galantamine: Cholinesterase Inhibitors for Alzheimer's Disease

Subas M. Sakya, Kapil Karki

Open publisher page 3 citations

Abstract

This chapter contains sections titled: Background Pharmacology Structure–Activity Relationship (SAR) Pharmacokinetics and Drug Metabolism Efficacy and Safety Syntheses of Donepezil Syntheses of Rivastigmine Syntheses of Galantamine

About this research paper

What this paper is about

This chapter contains sections titled: Background Pharmacology Structure–Activity Relationship (SAR) Pharmacokinetics and Drug Metabolism Efficacy and Safety Syntheses of Donepezil Syntheses of Rivastigmine Syntheses of Galantamine

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Background Pharmacology Structure–Activity Relationship (SAR) Pharmacokinetics and Drug Metabolism Efficacy and Safety Syntheses of Donepezil Syntheses of Rivastigmine Syntheses of Galantamine

Key concepts: Rivastigmine, Donepezil, Galantamine, Cholinesterase, Pharmacology, Medicine, Acetylcholinesterase, Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
Donepezil, Rivastigmine and Galantamine: Cholinesterase Inhibitors for Alzheimer's Disease — Research Paper | ScholarLens